Medication Used to Control Blood Sugar in People with Type 2 Diabetes ...
San Diego -- Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Join the discussion below, or Read more at Newswise.
#1 Oct 26, 2013
#3 Oct 26, 2013
planned and carried out
Add your comments below
|Gathering insights from your clinical practice||Jun '17||drzhivagogastro||2|
|Recruiting Fibromyalgia Providers (Mar '17)||Mar '17||FibromyalgiaGroup||1|
|CPC certified physicians coder (Aug '16)||Aug '16||Mindy||1|
|Study: Compound in Green Tea Could Help Fight R... (Feb '16)||Feb '16||ANN||1|
|Men With Rheumatoid Arthritis Have Increased Ri... (Sep '12)||Jan '16||Lore||18|
|Baptism by Radon: Cure for Erectile Dysfunction... (Aug '12)||Jan '16||Quattrone||13|
|HLA-B27 Positive/Negative inflamation tests/chr... (Jan '16)||Jan '16||TestQuestion||1|
Find what you want!
Search Rheumatology Forum Now
Copyright © 2017 Topix LLC